Eyebright Medical Technology Financials

Market Capitalization CN¥12.23 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	32.27
Forward PE	22.22
Price to Sales TTM	CN¥7.93
Price to Book MRQ	CN¥4.17
Enterprise to Revenue	8.03
Enterprise to EBITDA	20.88

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	24.40%
Operating Margin	24.48%
Return on Assets TTM	6.82%
Return on Equity TTM	13.03%

Income Statement

Revenue TTM	CN¥1,479,169,920
Revenue per Share TTM	CN¥7.71
Quarterly Revenue Growth	-8.20%
Gross Profit TTM	CN¥951,288,256
EBITDA	CN¥477,357,284
Net Income to Common TTM	CN¥360,968,288
Diluted EPS TTM	CN¥1.88
Quarterly Earnings Growth YoY	-29.90%

Balance Sheet

Total Cash MRQ	CN¥686,721,408
Total Cash per Share MRQ	CN¥3.55
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	21.25
Current Ratio MRQ	4.16
Book Value per Share MRQ	CN¥14.53

Cash Flow

Operating Cash Flow TTM	CN¥360,790,304
Levered Free Cash Flow TTM	CN¥48,892,588

688050 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	193,138,143
Float Shares	136,710,902
Avg 10 Volume	1,764,192
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	32.39%
% Held by Institutions	17.90%

Stock Price Summary

Beta	0.58
Fifty Two Week Low	CN¥58.89
Fifty Two Week High	CN¥108.44
Fifty Two Week Change	-61.49%
Day 50 MA	CN¥63.03
Day 200 MA	CN¥74.43

Dividends and Splits

Forward Annual Dividend Rate	CN¥1.40
Forward Annual Dividend Yield	2.31%
Trailing Annual Dividend Rate	CN¥0.35
Trailing Annual Dividend Yield	0.58%
Payout Ratio	18.62%
Dividend Date
Ex Dividend Date	2025-07-18
Last Split Factor
Last Split Date	2024-06-05